GoodRx GDRX
Valuation
Multiples measured against the stock's own five-year history
Above its usual level · 79th percentile, 5-year average -38.0x
#2610 of 2972 stocks by PE (1 = cheapest)
Near the bottom of its 5-year range · 18th percentile, 5-year average 3.7x
#2846 of 5311 stocks by PB (1 = cheapest)
Near the bottom of its 5-year range · 18th percentile, 5-year average 3.9x
#2131 of 5150 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 1.84 | – | 3.70 | 18% (cheaper than usual) | #2846 of 5311 (1 = cheapest) |
| PE | 58.17 | 27.14 | -37.99 | 79% (pricier than usual) | #2610 of 2972 (1 = cheapest) |
| PS | 1.52 | 1.47 | 3.86 | 18% (cheaper than usual) | #2131 of 5150 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on GDRX.
Sign in to join the discussion.